Skip to main content

Supplement guide

Milk Thistle (Silymarin): Evidence and Safety

Milk thistle contains silymarin, a mixture studied for liver conditions. Some studies report lower liver-enzyme levels, but reliable benefits for outcomes such as quality of life or survival remain unproven. It should not be used to diagnose a liver problem or replace established care.

Published by LongevityMate Editorial · Updated 2026-09-20 · 5 minute read

The short answer

Milk Thistle (Silymarin): Evidence and Safety explained

Milk thistle contains silymarin, a mixture studied for liver conditions. Some studies report lower liver-enzyme levels, but reliable benefits for outcomes such as quality of life or survival remain unproven. It should not be used to diagnose a liver problem or replace established care.See reference 1,See reference 2

On this page

The short answer

Milk Thistle (Silymarin): Evidence and Safety explained

Milk thistle contains silymarin, a mixture studied for liver conditions. Some studies report lower liver-enzyme levels, but reliable benefits for outcomes such as quality of life or survival remain unproven. It should not be used to diagnose a liver problem or replace established care.See reference 1,See reference 2

Milk thistle, silymarin and the product label

Milk thistle is the plant Silybum marianum. Silymarin is a mixture of compounds in its extract. The weight of plant material, the weight of an extract and its stated silymarin content describe different things; a large number on the front label does not identify a trial-equivalent product.See reference 1,See reference 6

Evidence by outcome and population

Human evidence
2025 Cochrane review: 17 trials, 2,069 adults with metabolic liver disease
What it can support
Benefits and harms remained unclear. Possible enzyme reductions were based on very uncertain evidence; no included trial reported mortality or quality of life.See reference 2
Human evidence
2025 meta-analysis: 55 trials across liver-injury settings
What it can support
Reported reductions in ALT and AST, with variation across conditions. Enzyme changes are not proof of survival benefit or reversal of liver disease.See reference 5
Human evidence
2012 placebo-controlled trial: 154 people with chronic hepatitis C
What it can support
Higher-than-customary silymarin doses did not improve the main ALT outcome compared with placebo over 24 weeks.See reference 3
Human evidence
2019 trial: 78 participants with a diagnosis of non-cirrhotic NASH
What it can support
No significant improvement in the main biopsy score; substantial diagnostic-entry problems limited interpretation.See reference 4

A lower ALT is not the same as a healthier liver

ALT and AST are laboratory outcomes. A supplement can change a laboratory measurement without proving that it prevents cirrhosis, improves how someone feels or extends life. The Cochrane review specifically identified the absence of mortality and quality-of-life reporting.See reference 2

This distinction helps reconcile favorable enzyme-focused reviews with cautious overall conclusions. Neither “nothing has ever improved” nor “milk thistle repairs the liver” accurately describes the evidence.See reference 2,See reference 5

What the studied doses do and do not mean

In the hepatitis C trial, participants received 420 mg or 700 mg of silymarin three times daily for 24 weeks. The trial involved people whose prior interferon-based therapy had failed. It did not demonstrate an ALT benefit and does not establish a self-treatment regimen for today’s patients.See reference 3

The 2019 NASH trial tested a standardized preparation at 420 mg or 700 mg three times daily for 48 weeks. Many participants did not meet the entry criteria on central pathology review. That limitation matters alongside the negative primary outcome; it is not a reason to assume higher doses work.See reference 4

Product quality is a separate question

A laboratory study tested 26 milk-thistle supplements bought in the United States and Czech Republic in 2016–2017. It found variable silymarin content, discrepancies with labels and contamination concerns. This was a defined historical sample, not a test of every product on sale now.See reference 6

Independent quality testing may help check composition and contaminants. It does not demonstrate that a product treats liver disease. Keep the exact product name, ingredients and lot information when discussing use or a suspected reaction.See reference 7

Side effects and situations needing caution

Oral milk thistle can cause bloating, nausea or gas. Allergic reactions may occur, particularly with allergies to related plants. Safety during pregnancy and breastfeeding is poorly established. Discuss medicines and supplements with a pharmacist or clinician before combining them.See reference 1

Evidence for blood-sugar effects comes from limited studies and cannot be turned into a diabetes treatment recommendation. “Natural” and “liver support” are marketing descriptions, not assurances of benefit or safety.See reference 1,See reference 7

Questions that make a liver-health claim more useful

Common questions

Is milk thistle a proven liver detox?

No. The trials reviewed here do not establish a general detoxification or liver-repair benefit. A liver-test abnormality needs its own assessment.See reference 1,See reference 2

Does a quality seal prove it works?

No. Quality assurance concerns manufacturing and composition; it does not establish clinical effectiveness.See reference 7

Should I replace liver treatment with silymarin?

No replacement is supported here. Discuss any supplement as part of the existing care plan.See reference 1,See reference 7

References

  1. 1. Milk Thistle

    NCCIHOfficial guidance

  2. 2. Silymarin for adults with metabolic dysfunction-associated steatotic liver disease

    Cochrane Database of Systematic ReviewsSystematic review

  3. 3. Effect of silymarin on liver disease in patients with chronic hepatitis C

    JAMARandomized trial

  4. 4. Silymarin in non-cirrhotics with non-alcoholic steatohepatitis

    PLOS ONERandomized trial

  5. 5. Are alterations needed in Silybum marianum administration practices? Meta-analysis of randomized trials

    BMC Complementary Medicine and TherapiesMeta-analysis

  6. 6. Poor chemical and microbiological quality of commercial milk thistle-based dietary supplements

    Scientific ReportsObservational study

  7. 7. Dietary Supplements: What You Need to Know

    NIH Office of Dietary SupplementsOfficial guidance

Editorial transparency

Published by
LongevityMate Editorial
Published
Updated

Medical disclaimer

General education only. This guide does not diagnose a condition, select treatment or recommend a supplement dose. Review your own results, symptoms and medicines with a qualified health professional.